Add To Watchlist

STIEFEL

The Wire

Glaxo buys Stiefel Laboratories for $2.9 billion

British drug maker GlaxoSmithKline PLC said Monday it will pay $2.9 billion to buy American dermatology business Stiefel Laboratories Inc. — the latest deal in a flurry of mergers and acquisitions in the pharmaceuticals industry.

Glaxo buys Stiefel Laboratories for $2.9 billion

British drugmaker GlaxoSmithKline PLC said Monday it will pay $2.9 billion to buy U.S. dermatology business Stiefel Laboratories Inc. — the latest deal in a flurry of mergers and acquisitions in the pharmaceuticals industry.

The Vine
This area needs news. Click here to seed the vine